• March 2022: Lu-177 vipivotide tetraxetan & Ga-68 gozetotide receive FDA approval for prostate cancer
  • May 2020: Cerianna (F-18 fluoroestradiol) receives FDA approval for ER+ breast cancer imaging
  • Access the latest issues of the JNM and the JNMT
  • Learn about the Facilitating Innovative Nuclear Diagnostics (FIND) Act
  • March 2021:SNMMI Statement on COVID-19 and Ventilation/Perfusion (V/Q) Lung Studies
  • March 2021:SNMMI Statement: The Effect of COVID-19 Vaccination on FDG PET/CT

Nuclear Medicine Technology Programs in the MVC


Iowa:

University of Iowa

Contact: Jay Smith, MA, CNMT, RT(R)(N)
Director, Nuclear Medicine Technology Education
319-356-2954
Email Jay


Kansas:

University of Kansas Medical Center

Contact: Jamie Noble, MSc, CNMT, RT(R)(N)(CT)
Program Director
Email Jamie


Missouri:

Saint Louis University

Contact: Julie Miller
Recruitment Specialist
314-977-2570
Email Julie


University of Missouri - Columbia

Contact: Jeff Galen, BHS-NM, M.Ed, CNMT
Program Director
573-882-7857
Email Jeff


Research Medical Center

Contact: Dylan Shimerda, CNMT, NMTCB(CT), RT(N)(MR)
Program Director
816-276-9570
Email Dylan


South Dakota:

None



Nebraska:

None


North Dakota:

None